Preclinical News and Research

RSS
New research project on systems biology of synapse proteins and ageing launched

New research project on systems biology of synapse proteins and ageing launched

Alnylam begins dosing in Phase I clinical trial with ALN-TTRsc for treatment of ATTR

Alnylam begins dosing in Phase I clinical trial with ALN-TTRsc for treatment of ATTR

Controlling hypertension earlier in life may limit brain changes associated with Alzheimer's disease

Controlling hypertension earlier in life may limit brain changes associated with Alzheimer's disease

Bruker introduces new products with scientific capabilities for research, industrial and applied markets

Bruker introduces new products with scientific capabilities for research, industrial and applied markets

CHOP expert to receive Pediatric Oncology Award from ASCO

CHOP expert to receive Pediatric Oncology Award from ASCO

ConservoCare obtains license options to develop nerve-block medical device for bladder control

ConservoCare obtains license options to develop nerve-block medical device for bladder control

Max Planck Florida Institute for Neuroscience gets grant for research into neurological disorders

Max Planck Florida Institute for Neuroscience gets grant for research into neurological disorders

Scientists to create new human monoclonal antibody targeting protein associated with cancer

Scientists to create new human monoclonal antibody targeting protein associated with cancer

Scientists sign licensing agreement for anticancer substances

Scientists sign licensing agreement for anticancer substances

Studies show local chemotherapy more effective in reducing tumor growth than regular chemotherapy

Studies show local chemotherapy more effective in reducing tumor growth than regular chemotherapy

Adult stem cell treatment for diabetic wounds

Adult stem cell treatment for diabetic wounds

Sleep problems may be indicator of early Alzheimer's disease

Sleep problems may be indicator of early Alzheimer's disease

Anti-cancer drug conjugates: an interview with Dr Andreas Menrad, CSO Ablynx and Dr Chris Martin, CEO Spirogen

Anti-cancer drug conjugates: an interview with Dr Andreas Menrad, CSO Ablynx and Dr Chris Martin, CEO Spirogen

Pneumococcal vaccine pre-clinical development supported by £0.2 million award from Biomedical Catalyst

Pneumococcal vaccine pre-clinical development supported by £0.2 million award from Biomedical Catalyst

Sildenafil does not improve exercise capacity in HF patients with preserved ejection fraction

Sildenafil does not improve exercise capacity in HF patients with preserved ejection fraction

Influenza drug: an interview with Dr Jenny McKimm-Breschkin, CSIRO

Influenza drug: an interview with Dr Jenny McKimm-Breschkin, CSIRO

Einstein researchers to develop drug-impregnated intravaginal ring for HIV prevention in women

Einstein researchers to develop drug-impregnated intravaginal ring for HIV prevention in women

Novel drug seems to increase effectiveness of usual chemotherapy against IBC

Novel drug seems to increase effectiveness of usual chemotherapy against IBC

Wiley, BPS and ASPET partner to publish Pharmacology Research & Perspectives

Wiley, BPS and ASPET partner to publish Pharmacology Research & Perspectives

Acceleron commences ACE-536 phase 2 study in beta-thalassemia

Acceleron commences ACE-536 phase 2 study in beta-thalassemia

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.